GMP manufacturing for cell culture products

GMP manufacturing for cell culture products
Product Description

Custom biomanufacturing for complex biologics using state-of-the-art facilities.

Bioworkshops

  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Start-up
Primary activities
Biopharmaceutical
Specifications
  • Details
    Custom production of antibody therapeutics, ADCs, soluble TCRs, TCEs, and fusion-proteins.
    • Compliance with US, EU, and China regulations.
    • Clinical and commercial scale
    • Fed-batch and concentrated fed-batch
    • Experience with variety of CHO cell lines
    • Multiple suites
    • Process development services available

  • Selling Points
    Quality Service;
    • Flexible capacity across clinical and commercial scale using fully single-use bioreactors from 50 to 2,000L.
    • Multiple platforms (Cytiva, Sartorius, Thermo)
    • Experience producing hundreds of different targeted therapeutics
  • Model
    Contract Services
  • Supplied from
    China

Bioworkshops

  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Start-up
Primary activities
Biopharmaceutical

More Products from Bioworkshops (67)

  • Etesevimab

    Product Etesevimab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Evolocumab

    Product Evolocumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Faricimab

    Product Faricimab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Fremanezumab

    Product Fremanezumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Frunevetmab

    Product Frunevetmab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Galcanezumab

    Product Galcanezumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Guselkumab

    Product Guselkumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Hyaluronidase Recombinant Human

    Product Hyaluronidase Recombinant Human

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Imdevimab

    Product Imdevimab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Lanadelumab

    Product Lanadelumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Lecanemab

    Product Lecanemab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Lokivetmab

    Product Lokivetmab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...

Bioworkshops resources (5)

  • Brochure Bioworkshops reliable antibody CDMO

    Overview of Bioworkshops for development, GMP manufacturing, and regulatory assurance for antibody therapeutics
  • Brochure Aseptic filling of biologics in liquid or lyophilized formats

    Bioworkshops services for aseptic filling include:Formulation development for liquid and lyophilized formatsManufacturing in compliance with Annex 1 requirementsBatch testing and releaseExecution of accelerated and long-term ICH stability studies 
    Development services include high-concentration formulations (to 200 mg/mL), lyophilization cycle development, and stress stability studies.


    Flexibility for clinical and commercial batches with three aseptic filling lines covering vials, PFS, and cartridges with validated batch sizes to 40,000 units.
  • Brochure Robust Cell Line Development by Bioworkshops

    High-productivity, stable CHO cell lines for clinical and commercial expression of therapeutic proteins: mAbs, bsAbs, fusion-proteins, TCRs, TCEs, naked ADCs and biosimilars.
    The Bioworkshops cell line development service offers choice of robust, royalty-free options for commercial production based on readily-available commercial media and supplements


    Over 200 stable cell lines have been produced for multiple product formats:
    Guaranteed stable to at least 60 PDLTiter to 12 g/LHost cell line DMF
  • Video Bioworkshops Drug Substance Manufacturing

    Virtual tour and description of Bioworkshops multiproduct cleanroom suites for manufacturing drug substance based on recombinant cell culture.
    Seed labsBioreactor halls with 50 - 2,000 L reactorsHarvest roomsPurificationSupport services for liquid and materials handlingAlso provides a summary of application experience.
  • Video Bioworkshops trio of aseptic oRABS filling lines

    Virtual tour of the three state-of-the-art aseptic filling lines operated at Bioworkshops in full compliance with Annex 1 requirements:Commerical-scale 200/min vial line for liquid and lyophilized products (2R - 50R)10,000/hr PFS/Cartridge line (long-format and standard)Ultra-low hold-up vial line for clinical batches